Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Abellan van Kan

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Nutrition, Health & Aging|August 7, 2009
Epidemiology and consequences of sarcopeniaG Abellan van Kan
The Journal of Frailty & Aging|April 13, 2016
Frailty Detection with the Gérontopôle Frailty Screening Tool (GFST)L Demougeot, G Abellan van Kan, B Vellas, et al.
Current Pharmaceutical Design|January 1, 2010
PUFA for prevention and treatment of dementia?I Carrié, G Abellan Van Kan, Y Rolland, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 6, 2024
Sarcopenia and poor nutritional status in older adultsL Calcaterra, G Abellan van Kan, Z Steinmeyer, et al.
The Journal of Frailty & Aging|April 20, 2016
Frailty and CognitionM Houles, M Canevelli, G Abellan van Kan, et al.
The Journal of Nutrition, Health & Aging|August 7, 2009
Descriptive study of nursing home residents from the REHPA networkY Rolland, G Abellan van Kan, S Hermabessiere, et al.
The Journal of Frailty & Aging|April 20, 2016
Gender Specific Associations between Frailty and Body CompositionD L Waters, G Abellan van Kan, M Cesari, et al.
The Journal of Nutrition, Health & Aging|March 1, 2008
The Geriatric Minimum Data Set for clinical trials (GMDS)G Abellan Van Kan, A Sinclair, S Andrieu, et al.
The Journal of Nutrition, Health & Aging|January 1, 2008
The I.A.N.A Task Force on frailty assessment of older people in clinical practiceG Abellan van Kan, Y Rolland, H Bergman, et al.
The Journal of Nutrition, Health & Aging|December 8, 2016
Is the 25-Hydroxy-Vitamin D Serum Concentration a Good Marker of Frailty?T Krams, M Cesari, S Guyonnet, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Nutrition, Health & Aging|August 7, 2009
Epidemiology and consequences of sarcopeniaG Abellan van Kan
The Journal of Frailty & Aging|April 13, 2016
Frailty Detection with the Gérontopôle Frailty Screening Tool (GFST)L Demougeot, G Abellan van Kan, B Vellas, et al.
Current Pharmaceutical Design|January 1, 2010
PUFA for prevention and treatment of dementia?I Carrié, G Abellan Van Kan, Y Rolland, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 6, 2024
Sarcopenia and poor nutritional status in older adultsL Calcaterra, G Abellan van Kan, Z Steinmeyer, et al.
The Journal of Frailty & Aging|April 20, 2016
Frailty and CognitionM Houles, M Canevelli, G Abellan van Kan, et al.
The Journal of Nutrition, Health & Aging|August 7, 2009
Descriptive study of nursing home residents from the REHPA networkY Rolland, G Abellan van Kan, S Hermabessiere, et al.
The Journal of Frailty & Aging|April 20, 2016
Gender Specific Associations between Frailty and Body CompositionD L Waters, G Abellan van Kan, M Cesari, et al.
The Journal of Nutrition, Health & Aging|March 1, 2008
The Geriatric Minimum Data Set for clinical trials (GMDS)G Abellan Van Kan, A Sinclair, S Andrieu, et al.
The Journal of Nutrition, Health & Aging|January 1, 2008
The I.A.N.A Task Force on frailty assessment of older people in clinical practiceG Abellan van Kan, Y Rolland, H Bergman, et al.
The Journal of Nutrition, Health & Aging|December 8, 2016
Is the 25-Hydroxy-Vitamin D Serum Concentration a Good Marker of Frailty?T Krams, M Cesari, S Guyonnet, et al.
Pageof 4